Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_001130438.3(SPTAN1):c.1330G>A(p.Val444Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00312 in 1,612,962 control chromosomes in the GnomAD database, including 142 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
SPTAN1 (HGNC:11273): (spectrin alpha, non-erythrocytic 1) Spectrins are a family of filamentous cytoskeletal proteins that function as essential scaffold proteins that stabilize the plasma membrane and organize intracellular organelles. Spectrins are composed of alpha and beta dimers that associate to form tetramers linked in a head-to-head arrangement. This gene encodes an alpha spectrin that is specifically expressed in nonerythrocytic cells. The encoded protein has been implicated in other cellular functions including DNA repair and cell cycle regulation. Mutations in this gene are the cause of early infantile epileptic encephalopathy-5. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010]
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SPTAN1. . Gene score misZ 5.523 (greater than the threshold 3.09). Trascript score misZ 7.9287 (greater than threshold 3.09). GenCC has associacion of gene with developmental and epileptic encephalopathy, 5, developmental and epileptic encephalopathy, West syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.004676819).
BP6
Variant 9-128580928-G-A is Benign according to our data. Variant chr9-128580928-G-A is described in ClinVar as [Benign]. Clinvar id is 139269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-128580928-G-A is described in Lovd as [Pathogenic]. Variant chr9-128580928-G-A is described in Lovd as [Benign]. Variant chr9-128580928-G-A is described in Lovd as [Likely_benign].
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0516 is higher than 0.05.
This variant is associated with the following publications: (PMID: 26539891, 31180159) -
Uncertain significance, no assertion criteria provided
clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System
-
- -
not specified Benign:2
Benign, criteria provided, single submitter
clinical testing
Genetic Services Laboratory, University of Chicago
Feb 08, 2016
- -
Benign, criteria provided, single submitter
clinical testing
Eurofins Ntd Llc (ga)
Nov 19, 2015
- -
Developmental and epileptic encephalopathy, 5 Benign:2
Benign, criteria provided, single submitter
clinical testing
Genome-Nilou Lab
Jul 15, 2021
- -
Benign, criteria provided, single submitter
clinical testing
Mendelics
May 28, 2019
- -
Abnormal brain morphology Pathogenic:1
Likely pathogenic, flagged submission
research
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
-
- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter
clinical testing
Ambry Genetics
Feb 10, 2017
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Early infantile epileptic encephalopathy with suppression bursts Benign:1